Hrt Financial LP Galapagos Nv Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Galapagos Nv stock. As of the latest transaction made, Hrt Financial LP holds 16,241 shares of GLPG stock, worth $387,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,241

Holding current value

$387,023

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$24.2 - $30.67 $393,032 - $498,111	16,241 New	16,241 $467,000
Q4 2021 Feb 14, 2022	SELL	$47.03 - $57.12 $1.86 Million - $2.26 Million	-39,608 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $1.69 Million - $2.28 Million	32,436 Added 452.26%	39,608 $2.08 Million
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $297,612 - $360,195	-4,322 Reduced 37.6%	7,172 $494,000
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $875,268 - $1.29 Million	11,494 New	11,494 $886,000
Q4 2020 Feb 16, 2021	SELL	$96.85 - $148.25 $267,306 - $409,170	-2,760 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$122.47 - $213.56 $338,017 - $589,425	2,760 New	2,760 $391,000
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $1.13 Million - $1.63 Million	-8,697 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$111.45 - $128.93 $969,280 - $1.12 Million	8,697 New	8,697 $1.12 Million

Others Institutions Holding GLPG

# of Institutions

Shares Held

12.3M

Call Options Held

69.1K

Put Options Held

42.7K

Bvf Inc San Francisco, CA

1.57M
Shares

$37.4 Million
1.44% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

1.41M
Shares

$33.6 Million
0.76% of portfolio
Prosight Management, LP Dallas, TX

1.03M
Shares

$24.5 Million
7.95% of portfolio
Logos Global Management LP San Francisco, CA

800K
Shares

$19.1 Million
3.05% of portfolio
Primecap Management CO Pasadena, CA

720K
Shares

$17.2 Million
0.02% of portfolio

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.57B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account